Cargando…
Suppression of head and neck cancer cell survival and cisplatin resistance by GRP78 small molecule inhibitor YUM70
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is one of the leading causes of cancer-related death worldwide. Surgical resection, radiation and chemotherapy are the mainstay of HNSCC treatment but are often unsatisfactory. Cisplatin is a commonly used chemotherapy in HNSCC; however, cisp...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875086/ https://www.ncbi.nlm.nih.gov/pubmed/36713577 http://dx.doi.org/10.3389/fonc.2022.1044699 |